Han Zeng Selected Research

Han Zeng Research Topics

Disease

24	Neoplasms (Cancer) 02/2024 - 12/2018
13	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2020
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2019
2	Kidney Neoplasms (Kidney Cancer) 09/2023 - 01/2019
2	Carcinoma (Carcinomatosis) 07/2023 - 01/2022
2	Hypoxia (Hypoxemia) 12/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2018
2	Insulin Resistance 10/2021 - 01/2020
2	Platelet Glycoprotein IV Deficiency 10/2021 - 01/2020
2	Malocclusion (Crossbite) 01/2021 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2019 - 12/2018
1	Medulloblastoma 02/2024
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2021
1	Fatty Liver 10/2021
1	Tertiary Lymphoid Structures 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2020
1	Obesity 03/2019
1	Cerebral Hemorrhage 01/2019
1	Carcinogenesis 12/2018
1	Aneurysm (Aneurysms) 05/2017

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
4	LipidsIBA 12/2022 - 12/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
3	CytokinesIBA 06/2022 - 01/2020
2	Interleukin-23 (Interleukin 23)IBA 09/2023 - 01/2019
2	Glutamine (L-Glutamine)FDA Link 09/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2020
2	LigandsIBA 01/2021 - 01/2020
2	NivolumabIBA 10/2020 - 01/2020
2	Olive OilIBA 03/2019 - 12/2018
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Cyclin-Dependent Kinase 6IBA 01/2024
1	PlatinumIBA 01/2024
1	Immune Checkpoint ProteinsIBA 07/2023
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2022
1	Neuropilin-1IBA 09/2022
1	Peptides (Polypeptides)IBA 02/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	MTOR InhibitorsIBA 01/2021
1	TitaniumIBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	Granzymes (Granzyme)IBA 12/2020
1	Interleukin-9 (Interleukin 9)IBA 12/2020
1	PerforinIBA 12/2020
1	Vitamin D FDA LinkGeneric 12/2020
1	pembrolizumabIBA 12/2020
1	Everolimus FDA Link 10/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Insulin ReceptorIBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	CC ChemokinesIBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2020
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Dietary Fats (Dietary Fat)IBA 03/2019
1	InterleukinsIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	AntibodiesIBA 01/2019
1	src-Family KinasesIBA 12/2018
1	Oleic Acid (Oleate)IBA 12/2018

Therapy/Procedure

8	Immunotherapy 07/2023 - 01/2019
6	Adjuvant Chemotherapy 11/2022 - 01/2020
4	Therapeutics 10/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2024 - 12/2020
1	Orthognathic Surgery 01/2021
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020
1	Transcranial Magnetic Stimulation 01/2019
1	Electrodes (Electrode) 05/2017
1	Radiofrequency Ablation 05/2017
1	Stents 05/2017